Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy

Background: Transvaginal ultrasound is one of the most common means to examine endometrial cavity lesions although its negative results are more valuable. Saline sonohysterography can reduce the number of false negative rates of endometrial lesions diagnoses in Tamoxifen consumers. The Objective of...

Full description

Bibliographic Details
Main Authors: Maryam Rahmani, Leila Farmanbordar, Ramesh Omranipour, Mahrooz Malek, Sanaz Zand
Format: Article
Language:English
Published: Kaviani Breast Disease Institute 2016-12-01
Series:Archives of Breast Cancer
Subjects:
Online Access:https://archbreastcancer.com/index.php/abc/article/view/117
id doaj-360bb342a86348ecba4ce553e7c4468b
record_format Article
spelling doaj-360bb342a86348ecba4ce553e7c4468b2020-11-25T03:11:22ZengKaviani Breast Disease InstituteArchives of Breast Cancer2383-04332016-12-013410.19187/abc.201634118-125101Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant TherapyMaryam Rahmani0Leila Farmanbordar1Ramesh Omranipour2Mahrooz Malek3Sanaz Zand4Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Department of Radiology, Tehran University of Medical Sciences, Tehran, IranAdvanced Diagnostic and Interventional Radiology Research Center (ADIR), Department of Radiology, Tehran University of Medical Sciences, Tehran, IranDivision of Surgical Oncology, Department of Surgery, Tehran University of Medical Sciences, Tehran, IranAdvanced Diagnostic and Interventional Radiology Research Center (ADIR), Department of Radiology, Tehran University of Medical Sciences, Tehran, IranKaviani Breast Diseases Institute (KBDI), Tehran, Iran Background: Transvaginal ultrasound is one of the most common means to examine endometrial cavity lesions although its negative results are more valuable. Saline sonohysterography can reduce the number of false negative rates of endometrial lesions diagnoses in Tamoxifen consumers. The Objective of this study was to determine the diagnostic values of saline infusion sonohysterography (SIS) and hysteroscopy as gold standard in diagnosis of endometrial pathologies in patients with breast cancer receiving adjuvant therapy with Tamoxifen for at least 6 months. Methods: This cross-sectional study was conducted on 40 patients with breast cancer who were treated with for at least 6 months and referred by the gynecologist for evaluation. Age, duration of Tamoxifen use and symptoms were recorded. Patients were examined by saline sonohysterography. Ultrasonic endometrial findings were recorded. Patients with positive findings were referred for hysteroscopy and biopsy was taken for pathologic examination. Then we compared the results. Results: In total, 40 patients with a mean age of 46.5±7.81 years and mean duration of Tamoxifen treatment 18.4 ±13.98 months were included. There were intrauterine lesions in 22 patients and they did not undergo hysteroscopy. For others, 9 patients with endometrial polyp (21.41%), 3 patients with endometrial hyperplasia (7.14%) were found. The accuracy of SSH in diagnosing endometrial polyp, endometrial hyperplasia and submucosal fibroma were 87.5%, 92.5% ,97.5%, respectively. Conclusions: Saline sonohysterography is a viable option for screening of the patients instead of endometrial biopsy as it has great negative predictive value. Sonohysterography is easy, non-invasive, inexpensive and has great accuracy. https://archbreastcancer.com/index.php/abc/article/view/117Tamoxifenbreast cancerendometrial lesionsendometrial cancersaline sonohysterography
collection DOAJ
language English
format Article
sources DOAJ
author Maryam Rahmani
Leila Farmanbordar
Ramesh Omranipour
Mahrooz Malek
Sanaz Zand
spellingShingle Maryam Rahmani
Leila Farmanbordar
Ramesh Omranipour
Mahrooz Malek
Sanaz Zand
Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy
Archives of Breast Cancer
Tamoxifen
breast cancer
endometrial lesions
endometrial cancer
saline sonohysterography
author_facet Maryam Rahmani
Leila Farmanbordar
Ramesh Omranipour
Mahrooz Malek
Sanaz Zand
author_sort Maryam Rahmani
title Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy
title_short Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy
title_full Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy
title_fullStr Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy
title_full_unstemmed Evaluation of Saline Sonohysterography Findings in Patients with Breast Cancer Receiving Tamoxifen Adjuvant Therapy
title_sort evaluation of saline sonohysterography findings in patients with breast cancer receiving tamoxifen adjuvant therapy
publisher Kaviani Breast Disease Institute
series Archives of Breast Cancer
issn 2383-0433
publishDate 2016-12-01
description Background: Transvaginal ultrasound is one of the most common means to examine endometrial cavity lesions although its negative results are more valuable. Saline sonohysterography can reduce the number of false negative rates of endometrial lesions diagnoses in Tamoxifen consumers. The Objective of this study was to determine the diagnostic values of saline infusion sonohysterography (SIS) and hysteroscopy as gold standard in diagnosis of endometrial pathologies in patients with breast cancer receiving adjuvant therapy with Tamoxifen for at least 6 months. Methods: This cross-sectional study was conducted on 40 patients with breast cancer who were treated with for at least 6 months and referred by the gynecologist for evaluation. Age, duration of Tamoxifen use and symptoms were recorded. Patients were examined by saline sonohysterography. Ultrasonic endometrial findings were recorded. Patients with positive findings were referred for hysteroscopy and biopsy was taken for pathologic examination. Then we compared the results. Results: In total, 40 patients with a mean age of 46.5±7.81 years and mean duration of Tamoxifen treatment 18.4 ±13.98 months were included. There were intrauterine lesions in 22 patients and they did not undergo hysteroscopy. For others, 9 patients with endometrial polyp (21.41%), 3 patients with endometrial hyperplasia (7.14%) were found. The accuracy of SSH in diagnosing endometrial polyp, endometrial hyperplasia and submucosal fibroma were 87.5%, 92.5% ,97.5%, respectively. Conclusions: Saline sonohysterography is a viable option for screening of the patients instead of endometrial biopsy as it has great negative predictive value. Sonohysterography is easy, non-invasive, inexpensive and has great accuracy.
topic Tamoxifen
breast cancer
endometrial lesions
endometrial cancer
saline sonohysterography
url https://archbreastcancer.com/index.php/abc/article/view/117
work_keys_str_mv AT maryamrahmani evaluationofsalinesonohysterographyfindingsinpatientswithbreastcancerreceivingtamoxifenadjuvanttherapy
AT leilafarmanbordar evaluationofsalinesonohysterographyfindingsinpatientswithbreastcancerreceivingtamoxifenadjuvanttherapy
AT rameshomranipour evaluationofsalinesonohysterographyfindingsinpatientswithbreastcancerreceivingtamoxifenadjuvanttherapy
AT mahroozmalek evaluationofsalinesonohysterographyfindingsinpatientswithbreastcancerreceivingtamoxifenadjuvanttherapy
AT sanazzand evaluationofsalinesonohysterographyfindingsinpatientswithbreastcancerreceivingtamoxifenadjuvanttherapy
_version_ 1724654508981616640